Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Bisaga

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Alcoholism, Clinical and Experimental Research|June 13, 2021
Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorderJohn J Mariani, Martina Pavlicova, Cale Basaraba, et al.
The American Journal of Psychiatry|October 20, 2018
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use DisorderMaria A Sullivan, Adam Bisaga, Martina Pavlicova, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experimentAdam C Brooks, Sandra D Comer, Maria A Sullivan, et al.
The American Journal of Psychiatry|January 11, 2017
Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus BuprenorphineMaria Sullivan, Adam Bisaga, Martina Pavlicova, et al.
Drug and Alcohol Dependence|April 21, 2018
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trialAdam Bisaga, Paolo Mannelli, Miao Yu, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|January 20, 2021
The utility of a formative one-station objective structured clinical examination for Substance use disorders in a dental curriculumFolarin Odusola, Jennifer L Smith, Eva Turrigiano, et al.
Experimental and Clinical Psychopharmacology|September 21, 2023
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trialKenneth M Carpenter, C Jean Choi, Cale Basaraba, et al.
O&G Open|January 21, 2026
Medication for Opioid Use Disorder and Perioperative Outcomes for Benign HysterectomyYongmei Huang, Alicia H Li, June Y Hou, et al.
The American Journal on Addictions|December 10, 2013
A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patientsWilfrid Noel Raby, Eric A Rubin, Fatima Garawi, et al.
Drug and Alcohol Dependence|July 19, 2015
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexoneAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Alcoholism, Clinical and Experimental Research|June 13, 2021
Pilot randomized placebo-controlled clinical trial of high-dose gabapentin for alcohol use disorderJohn J Mariani, Martina Pavlicova, Cale Basaraba, et al.
The American Journal of Psychiatry|October 20, 2018
A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use DisorderMaria A Sullivan, Adam Bisaga, Martina Pavlicova, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experimentAdam C Brooks, Sandra D Comer, Maria A Sullivan, et al.
The American Journal of Psychiatry|January 11, 2017
Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus BuprenorphineMaria Sullivan, Adam Bisaga, Martina Pavlicova, et al.
Drug and Alcohol Dependence|April 21, 2018
Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trialAdam Bisaga, Paolo Mannelli, Miao Yu, et al.
European Journal of Dental Education : Official Journal of the Association for Dental Education in Europe|January 20, 2021
The utility of a formative one-station objective structured clinical examination for Substance use disorders in a dental curriculumFolarin Odusola, Jennifer L Smith, Eva Turrigiano, et al.
Experimental and Clinical Psychopharmacology|September 21, 2023
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trialKenneth M Carpenter, C Jean Choi, Cale Basaraba, et al.
O&G Open|January 21, 2026
Medication for Opioid Use Disorder and Perioperative Outcomes for Benign HysterectomyYongmei Huang, Alicia H Li, June Y Hou, et al.
The American Journal on Addictions|December 10, 2013
A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patientsWilfrid Noel Raby, Eric A Rubin, Fatima Garawi, et al.
Drug and Alcohol Dependence|July 19, 2015
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexoneAdam Bisaga, Maria A Sullivan, Andrew Glass, et al.
Pageof 10